Clinical Research Directory
Browse clinical research sites, groups, and studies.
Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer
Sponsor: GrandPharma (China) Co., Ltd.
Summary
This real-world study tries to collect data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable liver metastases from Metastatic Liver Tumors From Primary Colorectal Cancer (mCRC) refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the safe and appropriate use of SIR-Spheres in China.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2023-10-15
Completion Date
2027-04-01
Last Updated
2023-10-13
Healthy Volunteers
No
Conditions
Interventions
Resin microspheres containing yttrium-90 (Y-90)
SIR-Spheres Y-90 resin microspheres are permanent implant and for single use only
Locations (1)
Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang University School of Medicine
Hangzhou, Zhejiang, China